Serum-derived exosomal miR-125a-3p predicts the response to anti-programmed cell death-1/programmed cell death-ligand 1 monotherapy in patients with non-small cell lung cancer
Kakeru Hisakane, Masahiro Seike, Teppei Sugano, Kuniko Matsuda, Takeru Kashiwada, Shinji Nakamichi, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Kaoru Kubota, Akihiko Gemma
Topics & Concepts
BiologyLung cancerCancer researchmicroRNAPD-L1CancerProgrammed cell deathCellNeuregulin 1OncologyImmunotherapyImmune systemInternal medicineApoptosisImmunologySignal transductionMedicineGeneCell biologyBiochemistryGeneticsExtracellular vesicles in diseaseCancer Immunotherapy and BiomarkersMicroRNA in disease regulation